🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Language Development in Children With Cochlear Implants and Speech-language Therapy Interventions

Recruitingn/aAges 32 Months - 48 MonthsAllAssistance Publique - Hôpitaux de Paris
NCT07447427 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cochlear implantation is currently offered to children with severe to profound prelingual hearing loss for whom hearing aids alone are insufficient to provide access to oral language (HAS, 2009). Speech-language therapy should be implemented concurrently to support the development of oral language (HAS, 2006). Several speech therapy approaches can be proposed. The auditory-phonological (AP) approach, recommended by HAS (HAS, 2006), is a child-centered rehabilitation method that relies on visual aids such as Cued Speech or French Sign Language (LSF) to supplement the auditory information transmitted by cochlear implants. Auditory-Verbal Therapy (AVT), widely developed in some countries, remains innovative in France. This therapy is more parent-centered, aiming to teach caregivers how to model language to optimally stimulate their child's language development. It excludes the use of visua

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Children with severe to profound prelingual hearing loss * Implanted between 8 and 24 months of age * At least 24 months of follow-up after implantation * No parental objection from legal guardians Exclusion Criteria: * Children with progressive hearing loss * Severe neurological pathology, identified by MRI and/or neuro-pediatric assessment * Suspected or diagnosed Autism Spectrum Disorder (ASD)
💊

What it tests

  • Speech-language therapy (observed standard care)
📍

Where

1 site
Hôpital Necker - Enfants Malades - Service d'ORL et chirurgie cervico-faciale
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy